Business
Mesoblast (ASX:MSB) share price rockets higher on major Novartis agreement – Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is surging higher on Friday after announcing a major agreement with Novartis for remestemcel-L…
The Mesoblast limited(ASX: MSB) share price is rocketing higher on Friday morning.
In early trade, the biotechnology company’s shares are up 20% to $3.95.
What did Mesoblast announce?
Mesoblast was busy with the announcements this morning, releasing its quarterly results and revealing a new collaboration with a major pharmaceutical company.
In respect to its quarterly results, Mesoblast reported a 92.3% decline in revenue to US$1.3 million for the first quarter. This was due largely to a US$15 million…
-
General18 hours agoWA government rolls out suite of housing assistance ahead of state budget
-
Noosa News19 hours agoPolice investigate fire at Borrodell Estate winery restaurant near Orange
-
Business19 hours agoLeading brokers name 3 ASX shares to buy today 16 June 2025
-
Business23 hours agoHow many Magnificent 7 stocks should I own?